Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. (Q51311899)
Jump to navigation
Jump to search
scientific article published in October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. |
scientific article published in October 2014 |
Statements
Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress (English)
Mahdieh Abbasalizad Farhangi